Albuquerque, NM, September 06, 2024 – The Diagnostics & Research Institute for Pathology at the Medical University of Graz, a leader in personalized patient care and one of the largest hospitals in Austria, has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics.
10 October 2024 | Join us for this 1-hour webinar to learn about HALO AP platforms with regulatory clearances supporting diagnostic workflows in the US (FDA cleared HALO AP Dx) and in the EU and UK (CE-IVDR marked HALO AP®).
HALO AP® and HALO AP Dx: Pathologist-Centric Enterprise Digital Pathology Platforms Read More »
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
HALO AP® 2.3 Features and Functionalities Read More »
Albuquerque, NM and New York, NY, August 27, 2024 – Indica Labs, a leading provider of computational pathology software and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.
Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.
Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Birmingham, UK and Albuquerque, NM, US (3 June 2024) – Indica Labs and Histofy have come together in a collaboration aimed at bringing Histofy’s cutting-edge AI tools into clinical practice via the established HALO AP® platform.
Histofy and Indica Labs Partner to Introduce AI Solutions to Pathology Practice Read More »
Albuquerque, NM, and Hamamatsu City, Japan – 22 May, 2024 – Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.
HALO AP seamlessly integrates with a wide selection of AI and image analysis innovations, LIS | LIMS, and diverse software platforms, offering unparalleled flexibility for your clinical workflow.
Integrating Innovation: HALO AP® as an AI Orchestration Platform for Digital Pathology Read More »
18 April 2024 | In this 1-hour webinar learn about SlideQC BF 3.0, an AI-based image quality control network that detects and segments most common artifacts including air bubbles, debris, folds, out of focus regions, and pen marker in both hematoxylin and eosin (H&E) and immunohistochemistry (IHC) images.
AI-based Slide Quality Control Workflows for Life Science and Clinical Applications Read More »
